CVE-2020-27269: In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insuli
CVE-2020-27269 is a medium-severity flaw (CVSS 5.7) affecting anydana-a firmware, anydana-i firmware, diabecare rs firmware. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.7 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.5% (top 57%) |
| CISA exploited list | No |
| Weakness | CWE-294 |
| Published | 2021-01-19 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2020-27269?
anydana-a firmware: upgrade to 3.0; anydana-i firmware: upgrade to 3.0; diabecare rs firmware: upgrade to 3.0. Exact commands for each OS are on this page.
Is CVE-2020-27269 being exploited?
CVE-2020-27269 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2020-27269 affect?
CVE-2020-27269 affects anydana-a firmware, anydana-i firmware, diabecare rs firmware. Severity is medium (CVSS 5.7). In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physica
How urgent is CVE-2020-27269?
Priority 31/100. No elevated risk signals yet.
Software pages
Related CVEs
- CVE-2020-27276 MEDIUM 5.7 UPGRADE UPGRADE SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump an
- CVE-2020-27272 MEDIUM 5.7 UPGRADE UPGRADE SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and
- CVE-2020-27270 MEDIUM 5.7 UPGRADE UPGRADE SOOIL Developments CoLtd DiabecareRS, AnyDana-i ,AnyDana-A, communication protocol of the insulin pump & AnyDa
- CVE-2020-27268 MEDIUM 6.5 UPGRADE UPGRADE In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in t
- CVE-2020-27266 MEDIUM 6.5 UPGRADE UPGRADE In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in t